Dr. Frederick Bennett's lab at the University of Pennsylvania focuses on developing innovative cell therapies for neurodegenerative diseases, particularly leukodystrophies like Krabbe disease. The research aims to improve the efficacy of hematopoietic stem cell transplantation by engineering immune cells that can effectively replace damaged brain cells. By optimizing these techniques in animal models, the lab is paving the way for potential new treatments to help young patients suffering from this devastating condition.

Dr. Alice S Chen-Plotkin's research focuses on understanding the differences in cognitive outcomes among patients with Lewy body diseases, which include Alzheimer's disease and Parkinson's disease. By studying the role of a protein called alpha-synuclein and its interactions with other disease markers, her lab aims to identify why some patients experience significant cognitive decline while others do not. The ultimate goal is to uncover new therapeutic targets to help manage or prevent these debilitating diseases.

Dr. Katheryn Alexandra Quilico Cousins leads a research lab focused on understanding frontotemporal lobar degeneration (FTLD), a group of neurodegenerative diseases. Her team works to identify biofluid biomarkers that can help classify different subtypes of FTLD and determine the progression of the disease. By analyzing biomarkers in cerebrospinal fluid and plasma, the lab aims to improve diagnosis and prognosis for patients suffering from this complex condition.

Dr. Sandhitsu Das's lab at the University of Pennsylvania focuses on understanding the relationship between tau pathology and neurodegeneration in Alzheimer's disease through advanced imaging techniques. The lab investigates how variations in tau levels can affect brain structure and cognitive function, aiming to identify different patient phenotypes that may influence disease progression. This research could improve clinical management and drug development for Alzheimer's disease by providing insights into individual vulnerabilities and resiliencies.

Dr. Kathryn Adamiak Davis leads a research lab focused on improving treatment outcomes for patients with drug-resistant epilepsy. The lab investigates the use of biomarkers to predict how well patients will respond to a device called responsive neurostimulation (RNS) that helps control seizures. By analyzing clinical and brain activity data, the lab aims to develop a predictive signature that could guide better treatment decisions for individuals seeking relief from their seizures.

Dr. David Irwin's research lab at the University of Pennsylvania focuses on understanding frontotemporal dementia (FTD), a serious condition that affects younger individuals and leads to significant changes in behavior, personality, and cognitive function. The lab investigates how glial cells and iron accumulation contribute to neurodegeneration in different types of FTD, particularly those influenced by tau or TDP-43 proteins. By analyzing human brain tissue and integrating advanced imaging techniques, the lab aims to uncover patterns that could lead to better diagnosis and treatment options for FTD.

Dr. Joshua Gold's lab investigates how the brain makes decisions by incorporating feedback from previous experiences. They focus on the interactions between two brain regions, the Anterior Cingulate Cortex (ACC) and the locus coeruleus, to understand how these interactions influence decision-making performance. By observing neuronal activity, the lab aims to uncover the mechanisms behind adaptive decision-making that relates to various mental health disorders.

Dr. Roy H. Hamilton's lab at the University of Pennsylvania focuses on the recovery of language abilities in individuals with aphasia, a common condition following stroke, and primary progressive aphasia (PPA), a form of dementia affecting language. The lab investigates the use of non-invasive brain stimulation techniques, specifically transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), to enhance communication therapy. By understanding how brain networks change after injury, the lab aims to develop personalized treatment strategies that improve language recovery outcomes for patients suffering from these language disorders.

Dr. Wenqin Luo's lab at the University of Pennsylvania investigates how our brains perceive the sensation of itching and the associated behavior of scratching. They focus on the role of specific neurons in the brain that are activated during scratching and how these neurons can suppress the itch sensation. By using advanced techniques like optogenetics and calcium imaging, the lab aims to uncover the neural circuits involved in mediating scratching responses and their implications for chronic conditions related to itch and pain.

Dr. Dennis Kolson's lab at the University of Pennsylvania focuses on understanding and preventing brain injury related to HIV infection. The lab investigates how combining existing HIV therapies with new neuroprotective agents may reduce neurological damage and improve cognitive function in patients. Their groundbreaking work uses Rhesus macaques to explore the potential of a drug called dimethyl fumarate to enhance brain recovery following early HIV infection.

The research lab led by Brian Litt at the University of Pennsylvania focuses on improving surgery outcomes for patients with epilepsy who do not respond to medication. By developing advanced methods to analyze brain imaging and electrical activity, the lab aims to create personalized approaches that help identify the best surgical options for individual patients. The lab collaborates with multiple surgical centers to standardize data sharing and improve surgical strategies for epilepsy treatment.

Dr. James J. Dowling's lab focuses on understanding a severe childhood muscle disease called X-linked myotubular myopathy (XLMTM), which is caused by mutations in the MTM1 gene. The research investigates the role of this gene in muscle development by exploring how MTM1 affects nuclear structures and gene expression related to muscle maturation. Through innovative mouse models and cutting-edge techniques, the lab aims to uncover the mechanics of this disease and contribute to potential therapy development.

Dr. Corey T. McMillan's lab at the University of Pennsylvania focuses on understanding complex neurodegenerative disorders, specifically frontotemporal degeneration (FTD) and amyotrophic lateral sclerosis (ALS). The lab investigates how genetic variations influence the diversity in symptoms and progression of these diseases. Their work aims to identify new biomarkers and mechanisms that might help in the development of effective treatments, utilizing advanced imaging and genetic analysis techniques.

Dr. Michael P. Nusbaum's research focuses on how hormones influence specific neural circuit states. By studying the stomatogastric ganglion in crabs, his lab investigates how different hormones modulate the activity of neural circuits that control chewing and food passage. This research not only advances our understanding of hormonal effects on brain function but also sheds light on the complexities of neural circuits in various behavioral states.

Dr. Jonathan Raper's lab at the University of Pennsylvania studies how the olfactory system is wired during embryo development. They focus on how sensory neurons, responsible for detecting smells, navigate and connect to specific targets in the brain's olfactory bulb. Using zebrafish as a model, the lab explores molecular signals that guide these neurons, which could lead to new treatments for conditions that impair the sense of smell, such as aging or certain genetic disorders.

Dr. Michael Platt's lab focuses on understanding how environmental stressors, like natural disasters, affect mental health and social behavior. Using the unique situation of free-ranging rhesus macaques impacted by a hurricane, the lab investigates the biological and social factors that contribute to resilience or vulnerability in response to stress. The findings could have important implications for improving mental health outcomes in humans by identifying protective factors from social connections.

Guo-Li Ming's lab at the University of Pennsylvania focuses on understanding how RNA modifications affect the brain's development and function. This research looks into the roles of various RNA modifications, particularly in relation to neurological disorders. By employing advanced techniques such as stem cell models, the lab aims to uncover the impact of these modifications on brain physiology and diseases like obesity and microcephaly.

Dr. Frances E. Jensen's lab at the University of Pennsylvania focuses on understanding how seizures affect brain function and contribute to diseases like Alzheimer's. The research explores the relationship between seizure activity in early life and its effects on cognitive abilities and synaptic connections throughout life. By studying animal models and human brain tissue, the lab aims to find new ways to treat or prevent cognitive decline associated with seizures and neurodegenerative diseases.

Dr. Shinjae Chung's lab at the University of Pennsylvania investigates how stress affects sleep patterns and cognitive function. They study the neural circuits involved in sleep regulation and how disturbances in sleep due to stress can lead to memory issues and affect mental health. The ultimate goal is to uncover insights that could lead to new therapies for sleep disorders triggered by stress.

Dr. Marc V Fuccillo's lab at the University of Pennsylvania focuses on understanding how specific types of neurons in the brain's striatum contribute to controlling behaviors and decisions. By studying interactions between different neuron types and neurotransmitters, the lab seeks to uncover the biological basis of goal-directed behaviors, which can be disrupted in various neuropsychiatric disorders. Their research combines advanced techniques such as optogenetics and calcium imaging to investigate both molecular mechanisms and circuit functions in real-time.